Inflammatory molecules such as TNFα, IL-6, and IL-17 can promote the breakdown of bone tissue and have been found to have higher levels in RA patients who had osteoporosis when compared to those without the condition [173,174]. This evidence concerns the gene IL17A and osteoporosis.